Rituximab as First-line Therapy for Severe Pemphigus: A Case Series and Review of Current Literature
Malaysian Journal of Dermatology
;
: 70-76, 2021.
Artigo
em Inglês
| WPRIM
| ID: wpr-961862
ABSTRACT
Summary@#Pemphigus refers to a group of life-threatening, autoimmune blistering disease that presents as blisters and erosions involving the skin and mucosa. Systemic corticosteroids and rituximab have been recommended as mainstay therapy for pemphigus vulgaris and pemphigus foliaceus. Herein, we report three cases of pemphigus vulgaris and a case of pemphigus foliaceus treated with rituximab as first-line therapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pênfigo
/
Rituximab
Idioma:
Inglês
Revista:
Malaysian Journal of Dermatology
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS